Menu
Back to Journals » Cancer Management and Research » Volume 10
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]
Authors Restelli U , Ceresoli GL, Croce D, Evangelista L, Maffioli LS , Gianoncelli L, Bombardieri E
Received 16 February 2018
Accepted for publication 16 February 2018
Published 27 March 2018 Volume 2018:10 Pages 613—614
Restelli U, Ceresoli GL, Croce D et al. Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study. Cancer Management and Research. 2017;9:789–800.
On page 796, above the Disclosure section, the Acknowledgment section is missing. The missing text is:
Acknowledgment
The authors thank Ray Hill, an independent medical writer, who provided English-language editing and journal styling prior to submission on behalf of Health Publishing & Services Srl. Editorial support was funded through an unconditional contribution by Bayer SpA.
Read the original article.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.